Vivani Medical Inc. sell shadow
Start price
10.03.21
/
0%
€26.55
Target price
10.03.22
-
Performance (%)
-86.89%
End price
11.03.22
€3.48
Summary
This prediction ended on 11.03.22 with a price of €3.48. The SELL prediction by shadow for Vivani Medical Inc. performed very well with a performance of -86.89%. This prediction was marked as speculative and is excluded from shadow's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vivani Medical Inc. | -6.135% | -6.135% | 53.769% | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
According to shadow what are the pros and cons of Vivani Medical Inc. for the foreseeable future?
Pros
Revenue growth >5% per year expected
Cons
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Dependend from some customers or products
Growths slower than the competition
EBIT decline/stagnation expected
Little innovation
Sustainability is little important
Probably not worthwhile Investment
Few uniques
high free float
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand
Business model of the past or high risk
Comments by shadow for this prediction
In the thread Second Sight Medical Products Inc diskutieren
Sell Second Sight Medical Products Inc
In the thread Trading Second Sight Medical Products Inc
Die von shadow gewählte maximale Laufzeit wurde überschritten